Franciscan Health

Indianapolis, Indiana 46237-8601

11 studies enrolling now · 17 studies all time

What they study most

Anal Fistula, Atrial Fibrillation, Atrial Fibrillation (AF), Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Carpal Tunnel Syndrome (CTS), Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Fallopian Tube Neoplasms

Studies at this site

• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
• A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — Recruiting now
• A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy — Recruiting now
• A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
• Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer — Recruiting now
• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now
• A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract — Recruiting now
• Tracking Results of Ablations to Combat AF Registry Generation 2 — Recruiting now
• A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal Fistulas — Recruiting now
• Abatacept in Immune Checkpoint Inhibitor Myocarditis — Recruiting now
• The KinematX Midcarpal Total Wrist Arthroplasty Registry — Recruiting now
• Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) — Running, not enrolling
• A Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant — Completed
• Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair — Running, not enrolling
• VCLIP Post-Market Study, Long-term Follow-up on LAA Exclusion Using AtriClip — Completed
• AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment — Running, not enrolling
• Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma — NO_LONGER_AVAILABLE